Hilgendorff Anne, Heidinger Kathrin, Bohnert Anette, Kleinsteiber Anja, König Inke R, Ziegler Andreas, Lindner Ulrike, Frey Georg, Merz Catherine, Lettgen Bernhard, Chakraborty Trinad, Gortner Ludwig, Bein Gregor
Department of Paediatrics, University of Giessen, Giessen, Germany.
Acta Paediatr. 2009 Jan;98(1):112-7. doi: 10.1111/j.1651-2227.2008.01014.x. Epub 2008 Sep 9.
Surfactant protein-D (SP-D) is a member of the collagenous subfamily of calcium-dependent lectins (collectins). Associations between single nucleotide polymorphisms (SNPs) of the human gene coding surfactant protein-D (SFTPD) and infectious pulmonary diseases have been established by several groups. As the outcome of very preterm infants is mainly determined by pulmonary morbidity, the aim of the present study was to investigate the potential association between sequence variations within the SFTPD gene and pulmonary morbidity in preterm infants below 32 weeks of gestational age (GA).
Four validated SNPs were genotyped with sequence-specific probes (TaqMan 7000) in 284 newborn infants below 32 weeks of GA. An association between the SNP rs1923537 and the development of respiratory distress syndrome (RDS) in the study population was found with a lower prevalence of RDS in infants having homozygous a minor allele genotype (odds ratio = 1.733, 95% confidence interval 1.139-2.636, adjusted p = 0.0408). Consecutively, the indicated polymorphism was found to be associated with a lower number of repetitive surfactant doses, and with a lower prevalence for the requirement of oxygen supplementation on day 28, as well as the use of diuretics.
The finding of an association of a variant of the SFTPD gene, that has previously been shown to be associated with increased SP-D serum levels in adult patients with acute respiratory failure, i.e. RDS in preterm infants, may provide a basis for the initial risk assessment of RDS and modification of surfactant treatment strategies. A role for SP-D in neonatal pulmonary adaptation has to be postulated.
表面活性蛋白-D(SP-D)是钙依赖性凝集素(collectins)胶原亚家族的成员。几个研究小组已经证实了编码表面活性蛋白-D(SFTPD)的人类基因单核苷酸多态性(SNP)与感染性肺部疾病之间的关联。由于极早产儿的预后主要由肺部疾病决定,本研究的目的是调查SFTPD基因序列变异与孕龄(GA)小于32周的早产儿肺部疾病之间的潜在关联。
采用序列特异性探针(TaqMan 7000)对284例GA小于32周的新生儿进行了4个已验证SNP的基因分型。研究人群中发现SNP rs1923537与呼吸窘迫综合征(RDS)的发生有关,纯合次要等位基因基因型婴儿的RDS患病率较低(优势比=1.733,95%置信区间1.139-2.636,校正p=0.0408)。随后,发现该多态性与重复使用表面活性剂的剂量减少、出生后28天补充氧气的需求率降低以及利尿剂的使用有关。
SFTPD基因变异与成人急性呼吸衰竭患者(即早产儿RDS)SP-D血清水平升高有关,这一发现可能为RDS的初始风险评估和表面活性剂治疗策略的调整提供依据。必须假定SP-D在新生儿肺适应中发挥作用。